相关实验视频
Updated: Jun 21, 2025

Modeling Chemotherapy Resistant Leukemia In Vitro
Published on: February 9, 2016
骨髓移植后的布利纳图莫马布维护疗法用于早期复发的儿科B细胞前体急性淋巴细胞白血病和淋巴细胞子集变化的分析
Takanari Abematsu1, Takuro Nishikawa1, Hiroshi Kasabata2
1Department of Pediatrics, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, JPN.
双特异性T细胞参与者Blinatumomab显示为B细胞前体急性淋巴细胞白血病 (BCP-ALL) 的安全移植后维持疗法. 这种免疫疗法帮助患者在骨髓移植后实现缓解并长期维持缓解.
科学领域:
- 免疫治疗是一种免疫疗法.
- 血液学 血液学 血液学
- 在瘤学瘤学.
背景情况:
- 布利纳图莫马布是B细胞前体急性淋巴细胞白血病 (BCP-ALL) 复发的有效免疫疗法.
- 布利纳马布在血造细胞移植后 (HSCT) 维持治疗中的作用仍然未确立.
- 本案例研究探讨了它在患有BCP-ALL的儿科患者的使用,该患者在维持治疗期间复发.
更多相关视频
06:08Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
Published on: February 10, 2023
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
相关概念视频
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Cells of the Adaptive Immune Response